Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-22

Clinical Trial Update: Sildenafil for Swimming-Induced Pulmonary Edema (SIPE) Prevention [Phase 2]

View source ↗

Summary

Phase 2 trial investigating sildenafil to prevent swimming-induced pulmonary edema; study completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SILDENAFIL (SILDENAFIL)

Snippet

Sponsor: Duke University | Conditions: Edema, Pulmonary, Immersion | Phase 2 | Status: COMPLETED | Results posted: 2022-11-22